Nimetazepam
A benzodiazepine derivative used as a hypnotic agent

Nimetazepam is a benzodiazepine derivative that is primarily used as a hypnotic agent. It is known for its sedative and anxiolytic properties, making it effective in the treatment of severe insomnia and anxiety disorders. Nimetazepam is marketed under various brand names, including Erimin.
Pharmacology[edit]
Nimetazepam acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor. This action results in increased neuronal inhibition, leading to its sedative and anxiolytic effects. The drug has a rapid onset of action and a relatively long half-life, which contributes to its effectiveness as a hypnotic.
Medical Uses[edit]
Nimetazepam is primarily prescribed for the short-term management of severe insomnia. It is also used in the treatment of anxiety disorders, where it helps to alleviate symptoms of anxiety and tension. Due to its potency and potential for dependence, it is generally recommended for use only when other treatments have failed.
Side Effects[edit]
Common side effects of Nimetazepam include drowsiness, dizziness, and impaired coordination. More serious side effects can include respiratory depression, hypotension, and amnesia. Long-term use can lead to tolerance, dependence, and withdrawal symptoms upon discontinuation.
Legal Status[edit]
Nimetazepam is classified as a controlled substance in many countries due to its potential for abuse and dependence. Its legal status varies, with some countries restricting its use to prescription-only, while others have banned it entirely.
Chemistry[edit]

Nimetazepam is chemically related to other benzodiazepines, sharing a similar core structure. It is a nitrobenzodiazepine, characterized by the presence of a nitro group at the 7-position of the benzodiazepine ring. This structural feature is thought to contribute to its pharmacological activity.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian